Perioperative Safety of Aprotinin in Coronary Artery Bypass Graft Surgery: Is there Life After BART?

By Augoustides John G.  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 557-560

Adis International

Access to resources Recommend Favorite

Meta-Analysis of Placebo-Controlled Trials of Aprotinin Assessing the Relative Risk of Reoperations in Patients Undergoing Coronary Artery Bypass Graft Surgery

By Kübler J.   Hecker-Barth G.  

Clinical Drug Investigation, Vol. 19, Iss. 3, 2000-03 ,pp. : 167-171

Adis International

Access to resources Recommend Favorite

Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety

By Kulik Alexander   Ruel Marc  

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 559-571

Informa Healthcare

Access to resources Recommend Favorite

Effects of Remifentanil and Fentanyl on the Cell-mediated Immune Response in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery

By von Dossow V   Luetz A   Haas A   Sawitzki B   Wernecke KD   Volk HD   Spies CD  

The Journal of International Medical Research, Vol. 36, Iss. 6, 2008-11 ,pp. : 1235-1247

Field House Publishing

Access to resources Recommend Favorite

Aprotinin: An Update of its Pharmacology and Therapeutic Use in Open Heart Surgery and Coronary Artery Bypass Surgery

By Peters D.C.   Noble S.  

Drugs, Vol. 57, Iss. 2, 1999-02 ,pp. : 233-260

Adis International

Access to resources Recommend Favorite